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ABSTRACT 
Hyperlipidaemia and diabetes are widely associated with liver injury. Senna and radish leaves have been reported to possess anti-diabetic, anti-
oxidant, and anti-hyperlipidemic activities. However, there is not enough information of these herbal medicines on hepatic function of rats with 
metabolic disorders. Therefore, the objective of the current study was to screen herbal extracts of senna and radish leaves on hepatic function 
in high fat fed and diabetic rats.  
Qualitative phytochemical investigation was done as per standard procedures. Quantitative phytochemical investigation was done using 
gravimetric method and HPLC analysis. Sprague–Dawley rats were fed on their respective diet (high fat/ normal pellet diet) for 16 weeks and 
thereafter, all the rats were divided into seven groups for high fat diet model and into eight groups for streptozotocin and high fat diet-induced 
diabetes model. Treatment duration was 07 weeks for high fat diet models and 03 weeks for diabetes model. Parameters studied in these 
models were body weight, food intake, alanine aminotransferase, aspartate aminotransferase, liver weight and liver histopatho logy. Qualitative 
phytochemical investigation revealed the presence of flavonoids, glycosides, tannins, carbohydrates and saponins, while quantitative analysis 
revealed presence of rutin and myricetin in radish extract and presence of sennoside and rutin in senna extract. Treatment groups showed 
significant decrease in body weight, food intake, alanine aminotransferase and aspartate aminotransferase. Significant improvement was 
observed in liver histopathology in extract treated groups. It is concluded that senna and radish leaf extracts significantly ameliorated liver 
function.  
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INTRODUCTION  
Diabetes and obesity are the most common cause of liver 
disease1,2. Hyperglycemia with insulin resistance in diabetes 
can destroy the hepatocytes3,4, while in obesity excessive fat 
accumulation in the liver is associated with hepatic 
steatosis5. Hyperglycemia and hepatic steatosis can 
contribute to increased morbidity and mortality among 
patients of metabolic disorders 1,4.Hyperlipidemia, 
hyperglycemia, insulin resistance and oxidative stress 
contribute to the liver disease in the patients of metabolic 
disorders6. Cassia angustifolia (senna) is used traditionally as 
anti-inflammatory and in obesity7, while Raphanus sativus 
(radish) is used for liver problems and in inflammation8. 
Both plants have been reported to possess anti-
hyperlipidemic9 and anti-oxidant10,11 activities.  
MATERIAL AND METHOD 
Aqueous extract of Cassia angustifolia (CAE) and 
hydroalcoholic extract of Raphanus sativus (RSE) was used in 
this study at the dose levels of 400 mg/kg and 800 mg/kg, 
orally. Qualitative phytochemical investigation was done as 
per standard procedures12, while quantitative phytochemical 
investigation was done using gravimetric method13 and 
HPLC analysis. Sprague–Dawley rats were fed on their 
respective diet (high fat/ normal pellet diet) for 16 weeks 
and thereafter, all the rats were divided into seven groups 
for high fat diet model and into eight groups for 
streptozotocin and high fat diet-induced diabetes model. 
Treatment duration was 07 weeks for high fat diet models 
and 03 weeks for diabetes model. Parameters studied in 
these models were body weight, weight gain, food intake, 
alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), liver weight and liver histopathology 14,15. 
RESULT AND DISCUSSION  
Qualitative phytochemical analysis of the extracts showed 
presence of flavonoids, glycosides, saponins and/or tannins. 
Quantitative analysis by gravimetric analysis, indicated 
presence of flavonoids: 5.2%, cardiac glycosides: <2%, 
saponins: 24.52% and tannins: 2.91% in RSE and glycoside: 
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2.62%, flavonoids: 4.62%, saponins: <2% in CAE. HPLC 
method, indicated presence of rutin: 0.12 % and myricetin: 
0.03% in RSE and Sennoside A: 0.73 %, Sennoside B: 1.55%, 
and rutin: 0.15 % in CAE. Significant decrease in body weight 
and food intake was observed in extracts treated groups as 
compared to HFD group in high fat diet model (Table 1). 
Decreased body weight and food intake in extract treated 
groups are beneficial to reduce progression of liver disease 
associated with high fat diet intake. In high fat model, both 
RSE and CAE reduced AST level (Table 1). In diabetic rats, 
treatment with RSE reduced serum AST and ALT level (Table 
2). Flavonoids, glycoside and saponins, present in both 
extracts, resulted in the amelioration of liver enzymes. 
Histopathology of liver in high fat fed model (Figure 1) 
revealed that a high degree of steatosis was developed in the 
HFD group, whereas no histological abnormalities were seen 
in the NPD group. Microvesicular steatosis was observed in 
all groups fed with HFD. Treatment groups showed 
regenerating hepatocytes, mild intracytoplasmic vacuolation 
and mild pigmentation. Significant decrease in 
microvesicular steatosis was observed in RSE4, RSE8, CAE4 
and CAE8 groups as compared to the HFD group. 
Histopathology of liver in diabetes model (Figure 2) revealed 
that a high degree of steatosis and structural changes were 
developed in the HFD+STZ group. Steatosis was observed in 
all groups fed with the HFD. Congestion, vacuolation and 
cytoplsmic degeneration was observed in HFD+STZ group. 
Significant amelioration in structure and steatosis was 
observed in RSE4, RSE8, CAE4 and CAE8 groups as compared 
to the HFD+STZ group. All section showed vacuolation in 
periportal cell, congestion and RBCs except NPD and 
NPD+STZ group. RSE and CAE treatment significantly 
reduced excess fat deposition in the liver as indicated by 
liver histopathology. 
  
Table 1 Effect of senna and radish extracts on the study parameters in high fat diet model 
Groups 
Parameters 
Initial body 
weight (g) 
Final body 
weight (g) 
Body 
weight 
gain (g) 
Food 
intake 
(g/rat/day) 
AST 
(U/L) 
ALT 
(U/L) 
Relative 
organ 
weight % 
NPD 225.00±4.65 
245.00 ± 
5.77 
20.00±1.83 10.37±0.09 139.14±12.72 36.61±3.25 2.78±0.19 
HFD 272.50±7.04z 323.33±7.60z 50.83±4.73z 10.61±0.08 338.62±30.83z 43.33±3.45 2.93±0.19 
RSE (400 mg/kg, 
p.o.) 
273.33±7.26 293.33±7.49a 20.00±4.47c 10.31±0.01a 191.19±13.86c 40.18±4.88 2.58±0.13 
RSE8 (800 mg/kg, 
p.o.) 
275.00±7.30 286.67±6.15b 11.67±5.58c 10.20±0.05b 371.19±44.13 41.88±3.24 2.82±0.13 
CAE4 (400 
mg/kg, p.o.) 
263.33±5.73 295.00±5.77b 31.67±1.67a 10.27±0.08a 167.67±7.12c 57.28±7.28 3.15±0.17 
CAE8 (800 
mg/kg, p.o.) 
265.00±2.89 291.67±5.27c 26.67±3.07b 10.28±0.03a 213.55±13.67b 76.41±9.22b 3.45±0.15 
Atorvastatin, AT 
(10 mg/kg, p.o.) 
260.83±3.00 305.00±4.28 44.17±3.27 10.50±0.07 244.50±7.87 53.74±4.97 2.98±0.22 
Values are expressed as Mean ± SEM (n= 6), analyzed by One way ANOVA followed by Bonferroni Test. zdenotes P< 0.001 vs. 
NPD, a denotes P< 0.05, bdenotes P< 0.01 and c denotes P< 0.001 vs. HFD. 
 
Table 2 Effect of senna and radish extracts on the study parameters in diabetes model 
Groups Parameters 
Initial body 
weight (g) 
Final body 
weight (g) 
Body 
weight 
gain (g) 
Food 
intake 
(g/rat/day) 
AST 
(U/L) 
ALT 
(U/L) 
Relative 
organ 
weight % 
NPD 221.67±8.63 233.33±8.82 11.67±1.67 9.59±0.04 148.83± 4.00 47.52±4.09 2.99±0.32 
NPD+STZ 230.83±2.39 240.83±2.01 10.00±2.89 10.25±0.04 150.70± 8.77 51.47±1.67 3.44±0.12 
HFD+STZ 245.00±3.16 265.00±3.42
x
 20.00±1.83 19.90±0.13
z
 188.35±11.87
y 59.67±2.13x 3.55±0.10 
RSE4 (400 mg/kg, 
p.o.) 
242.50±2.50 259.17±5.97 16.67±4.22 19.62±0.18 144.59±5.62b 46.22±0.94b 3.59±0.32 
RSE8 (800 mg/kg, 
p.o.) 
245.00±3.42 271.67±5.73 26.67±3.07 21.11±0.25 132.48±7.68c 45.62±1.54b 3.18±0.22 
CAE4 (400 mg/kg, 
p.o.) 
244.17±8.51 266.67±8.63 22.50±2.50 20.14±0.69 199.54±5.08 60.48±2.72 3.11±0.24 
CAE8 (800 mg/kg, 
p.o.) 
243.33±7.60 263.33±7.38 20.00±1.83 19.98±0.18 186.53±5.48 62.68±2.19 3.36±0.12 
Metformin, MET 
(100 mg/kg, p.o.) 
239.17±4.73 255.00±5.48 15.83±2.01 18.38±0.09b 135.16±5.52c 46.76±1.53b 3.39±0.50 
Values are expressed as Mean ± SEM (n=6), analyzed by One way ANOVA followed by Bonferroni Test. 
 x denotes P< 0.05 and zdenotes P< 0.001 vs. NPD, bdenotes P< 0.01 and c denotes P< 0.001 vs. HFD+STZ. 
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Figure 1 Effect of senna and radish extracts on the histology of liver in high fat diet model (H&E staining, 100× 
magnification, red arrow=fat depots, black arrow=nucleus, green arrow= congestion, yellow arrow=binucleated 
hepatocyte, blue arrow= mitotic figure 
 
  
 
Figure 2 Effect of senna and radish extracts on the histology of liver in diabetes model (H&E staining, 100× 
magnification), red arrow =fat depots, black arrow=nucleus, green arrow= congestion, yellow arrow=binucleated hepatocytes 
 
CONCLUSION 
It is concluded that leaf extracts of senna and radish 
significantly improved liver function, due to their 
antihyperlipidemic and antioxidant actions as well as 
presence of bioactive constituents like flavonoids, glycosides, 
saponins and tannins.  
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